Answers are grounded in this paper and cite their sources.
Accurate quantification of viable Bifidobacterium animalis subsp. lactis is essential for probiotic quality and functionality, yet remains challenging in complex multi-strain products and diverse matrices. Here, we developed a pan-genomic-driven propidium monoazide–quantitative PCR (PMA-qPCR) assay, enabling robust and precise enumeration of viable B. lactis in both single-strain and complex formulations. Using a pan-genomic approach combined with two-tiered in silico and experimental validation, we identified a novel subspecies-specific target, the pyridoxal phosphate homeostasis protein, which allowed exclusive detection without cross-reactivity among 36 non-target strains, including closely related taxa. The optimized PMA protocol demonstrated high strain-independent universality, effectively excluding signals from non-viable cells while maintaining sensitivity (LOD 10 3 CFU/mL) and strong linearity (R 2 > 0.99, 10 3 –10 8 CFU/mL) across diverse sample matrices and excipients. Importantly, the method enabled accurate quantification of B. lactis in complex multi-strain probiotic products, and in long-stored samples, PMA-qPCR detected higher viable counts than traditional plate counting; this was corroborated by flow cytometry and single-cell D₂O-labeled Raman spectroscopy, revealing physiologically intact cells beyond culturability. Collectively, these findings establish the pan-genomic-driven PMA-qPCR as a culture-independent, high-resolution tool for reliable quality control and label verification of B. lactis , supporting standardized testing, regulatory compliance, and multidimensional viability assessment in increasingly complex commercial probiotic products.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: